Results from an early-phase randomized clinical trial of Chinese vaccine candidate Covid-19 CoronaVac show that the formulation appears safe and induces an antibody response in volunteers aged 18 to 59 years. The results, published in The Lancet, add to the number of candidate vaccines tested that have been found safe. …
Read More »
BEIJING: A Covid-19 vaccine developed by a state-owned Chinese pharmaceutical company was administered to about one million people under the government’s emergency use scheme, the company’s president said. “In terms of emergency use, the vaccines were given to almost a million people and there has not been a single case …
Read More »
By: Reuters | November 18, 2020 8:36:37 am A box of the Sinovac Biotech Ltd. SARS-CoV-2 vaccine in Sao Paulo, Brazil, on Wednesday, November 11, 2020. Brazil reversed its decision to suspend trials of the Sinovac coronavirus vaccine amid criticism that the decision was politicized. Photographer: Jonne Roriz / Bloomberg …
Read More »
Results of an early-phase randomized clinical trial of a Chinese vaccine candidate based on the inactivated complete SARS-CoV-2 virus (CoronaVac) show that the formulation appears safe and induces an antibody response in healthcare volunteers aged 18 to 59 years. . The results, published Tuesday in The Lancet Infectious Diseases Journal, …
Read More »